The position of imidazopyridine and metabolic activation are pivotal factors in the antimutagenic activity of novel imidazo[1,2-a] pyridine derivatives

European Journal of Pharmacology

Volumn 715, Issue 1-3, 2013, Pages 212-218

  El Sayed, Wael M ^a,b   Hussin, Warda A ^c   Al Faiyz, Yasair S ^a   Ismail, Mohamed A ^a,d  

^a KING FAISAL UNIVERSITY   (Saudi Arabia)

^b Ain Shams University   (Egypt)

^c Al Azhar University   (Egypt)

^d Mansoura University   (Egypt)

Author keywords

Antimutagenicity; Benzo a pyrene; Imidazo 1,2 a pyridines; Sodium azide

Indexed keywords

IMIDAZOPYRIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIMUTAGENIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DEMETHYLATION; DRUG ACTIVITY; MALE; METABOLIC ACTIVATION; NONHUMAN; PRIORITY JOURNAL; RAT; REVERTANT; SALMONELLA;

ANTIMUTAGENICITY; BENZO[A]PYRENE; IMIDAZO[1,2-A]PYRIDINES; SODIUM AZIDE;

ANIMALS; ANTIMUTAGENIC AGENTS; ANTINEOPLASTIC AGENTS; MALE; MICE; MICROBIAL VIABILITY; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; SALMONELLA TYPHIMURIUM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84885480284     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.05.018     Document Type: Article

References (25)

1. Al-Tel, T.H., Al-Qawasmeh, R.A., Zaarour, R., 2011. Design, synthesis and in vitro antimicrobial evaluation of novel Imidazo[1,2-a]pyridine and imidazo[2,1-b] [1,3]benzothiazole motifs. Eur. J. Med. Chem. 46, 1874-1881.
2. Bendaly, J., Metry, K.J., Doll, M.A., Jiang, G., States, J.C., Smith, N.B., Neale, J.R., Holloman, J.L, Pierce, W.M., Hein, D.W., 2009. Role of human CYP1A1 and NAT2 in 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced mutagenicity and DNA adducts. Xenobiotica 39, 399-406.
3. Biftu, T., Feng, D., Fisher, M., Liang, G.B., Qian, X., Scribner, A., Dennis, R., Lee, S., Liberator, P.A., Brown, C, Gurnett, A., Leavitt, P.S., Thompson, D., Mathew, J., Misura, A., Samaras, S., Tamas, T., Sina, J.F., McNulty, K.A., McKnight, CG., Schmatz, D.M., Wyvratt, M., 2006. Synthesis and SAR studies of very potent imidazopyridine antiprotozoal agents. Bioorg. Med. Chem. Lett. 16, 2479-2483.
4. Cheng, K.W., Chen, F., Wang, M., 2006. Heterocyclic amines: chemistry and health. Mol. Nutr. Food Res. 50, 1150-1170. (Pubitemid 46043100)
5. El-Sayed, WM., Hussin, W.A., 2013. Antimutagenic and antioxidant activity of novel 4-substituted phenyl-2,2'-bichalcophenes and aza-analogues. Drug Des. Devel. Ther. 7, 73-81.
6. El-Sayed, W.M., Hussin, W.A., Franklin, M.R., 2007. The anti-mutagenicity of 2-substitiuted selenazolidine-4-(R)-carboxylic acids. Mutat. Res. 627, 136-145.
7. Ganguly, S., Vithlani, V.V., Kesharwani, A.K., Kuhu, R., Baskar, L., Mitramazumder, P., Sharon, A., Dev, A., 2011. Synthesis, antibacterial and potential anti-HIV activity of some novel imidazole analogs. Acta. Pharm. 61, 187-201.
8. Greenblatt, DJ., Roth, T, 2012. Zolpidem for insomnia. Expert Opin. Pharmacother. 13, 879-893.
9. Hong, CE., Cho, M.C, Jang, H.A., Lyu, S.Y., 2011. Mutagenicity and anti-mutagenicity of Acanthopanax divaricatus var. albeofructus. J. Toxicol. Sci. 36, 661-668.
10. Hopkins, N.E., Foroozesh, M.K., Alworth, WL, 1992. Suicide inhibitors of cytochrome P450 1A1 and P450 2B1. Biochem. Pharmacol. 44, 787-796.
11. Ismail, MA, Arafa, R.K., Wenzler, T., Brun, R., Tanious, FA, Wilson, W.D., Boykin, D.W., 2008. Synthesis and antiprotozoal activity of novel bis-benzamidino imidazo [1,2-a]pyridines and 5,6,7,8-tetrahydro-imidazo[1,2-a] pyridines. Bioorg. Med. Chem 16, 683-691. (Pubitemid 351163070)
12. Ismail, M.A., Brun, R., Wenzler, T., Tanious, F.A., Wilson, W.D., Boykin, D.W., 2004. Novel dicationic imidazo[1,2-a]pyridines and 5,6,7,8-tetrahydro- imidazo[1,2-a] pyridines as antiprotozoal agents. J. Med. Chem. 47, 3658-3664. (Pubitemid 38822026)
13. Kim, S.R., Kokubo, K., Matsui, K., Yamada, N., Kanke, Y., Fukuoka, M., Yamada, M., Nohmi, T, 2005. Light-dependent mutagenesis by benzo[a]pyrene is mediated via oxidative DNA damage. Environ. Mol. Mutagen. 46, 141-149. (Pubitemid 41642305)
14. Kogan, G., Skorik, YA, Zitnanová, I., Krizková, L, Duracková, Z., Gomes, CA, Yatluk, Y.G., Krajcovic, J., 2004. Antioxidant and antimutagenic activity of N-(2-carboxyethyl) chitosan. Toxicol. Appl. Pharmacol. 201, 303-310. (Pubitemid 39593628)
15. Langouët, S., Welti, D.H., Kerriguy, N., Fay, LB., Huynh-Ba, T., Markovic, J., Guengerich, F.P., Guillouzo, A., Turesky, R.J., 2001. Metabolism of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in human hepatocytes: 2-amino-3-methylimidazo[4,5-f]quinoxaline-8-carboxylic acid is a major detoxification pathway catalyzed by cytochrome P450 1A2. Chem. Res. Toxicol. 14, 211-221. (Pubitemid 32173323)
16. Lee, H., Jung, K.H., Jeong, Y, Hong, S., Hong, S.S., 2013. HS-173, a novel phospha-tidylinositol 3-kinase (PI3K) inhibitor, has anti-tumor activity through promoting apoptosis and inhibiting angiogenesis. Cancer Lett. 328, 152-159.
17. Lee, H., Li, G.Y, Jeong, Y, Jung, K.H., Lee, J.H., Ham, K., Hong, S., Hong, S.S., 2012. A novel imidazopyridine analogue as a phosphatidylinositol 3-kinase inhibitor against human breast cancer. Cancer Lett. 318, 68-75.
18. Li, G.Y., Jung, K.H., Lee, H., Son, M.K., Seo, J.H., Hong, S.W., Jeong, Y., Hong, S., Hong, S.S., 2012. A novel imidazopyridine derivative, HS-106, induces apoptosis of breast cancer cells and represses angiogenesis by targeting the PI3K/mTOR pathway. Cancer Lett. 12, 601-605.
19. Liu, Y., Kumar, A., Depauw, S., Nhili, R., David-Cordonnier, M.H., Lee, M.P., Ismail, M.A., Farahat, A.A., Say, M., Chackal-Catoen, S., Batista-Parra, A., Neidle, S., Boykin, D.W., Wilson, W.D., 2011. Water-mediated binding of agents that target the DNA minor groove. J. Am. Chem. Soc. 133, 10171-10183.
20. Luch, A., Baird, W.M., 2005. Metabolic activation and detoxification of polycyclic aromatic hydrocarbons. In: Luch, A.A. (Ed.), The Carcinogenic Effects of Polycyclic Aromatic Hydrocarbons. Imperial College Press, London, pp. 19-96.
21. Maron, D.M., Ames, B.N., 1983. Revised methods for the Salmonella mutagenicity test. Mutat. Res. 113, 173-215. (Pubitemid 13120319)
22. Sugimura, T., 1997. Overview of carcinogenic heterocyclic amines. Mutat. Res. 376, 211-219. (Pubitemid 27248605)
23. Tiso, M., Strub, A., Hesslinger, C., Kenney, C.T., Boer, R., Stuehr, D.J., 2008. BYK191023 (2-[2-(4-methoxy-pyridin-2-yl)-ethyl]-3h-imidazo[4,5-b] pyridine) is an NADPH-and time-dependent irreversible inhibitor of inducible nitric-oxide synthase. Mol. Pharmacol. 73, 1244-1253. (Pubitemid 351439206)
24. Zeiger, E., 1998. Identification of rodent carcinogens and noncarcinogens using genetic toxicity tests: Premises, promises, and performance. Regul. Toxicol. Pharmacol. 28, 85-95. (Pubitemid 29076774)
25. Zenser, T.V., Lakshmi, V.M., Schut, H.A., Zhou, H.J., Josephy, P.D., 2009. Activation of aminoimidazole carcinogens by nitrosation: mutagenicity and nucleotide adducts. Mutat. Res. 673, 109-115.